| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |